CNTN1 and myasthenia gravis: Similar to other IgG4 autoimmune diseases such as myasthenia gravis with antibodies to muscle-specific kinase (MuSK-MG), anti-CNTN1 autoimmune nodopathy generally responds well to rituximab, a monoclonal antibody against B lymphocyte membrane protein CD20 (5, 6).